Stock Price
4.17
Daily Change
0.15 3.73%
Monthly
8.88%
Yearly
46.83%
Q1 Forecast
3.78

Acasti Pharma reported $-3.7M in EBIT for its fiscal quarter ending in December of 2024.





Ebit Change Date
Acasti Pharma USD -3.7M 1.13M Dec/2024
Addus HomeCare USD 42.28M 9.34M Dec/2025
Amarin USD -1.7M 8.47M Sep/2025
Cassava Sciences USD -11.86M 33.53M Sep/2025
Knight Therapeutics CAD 3.2M 1.29M Sep/2024
Option Care Health USD 91.5M 6.99M Dec/2025
Organigram Holdings CAD -28.05M 25.94M Sep/2025
Tilray USD -20.01M 9.34M Sep/2025